HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reversibility of hypogonadotropic hypogonadism in a patient with the juvenile form of hemochromatosis.

AbstractOBJECTIVE:
To report a case of complete reversibility of hypogonadotropic hypogonadism with intensive venesection treatment in juvenile hemochromatosis.
DESIGN:
Case report.
SETTING:
Endocrine department of Hippocrateion Hospital of Athens.
PATIENT(S):
A 25-year-old man who presented with hypogonadotropic hypogonadism and severe iron overload due to juvenile hemochromatosis and who was initially treated with phlebotomies and androgen substitution.
INTERVENTION(S):
Intensification of chelation therapy.
MAIN OUTCOME MEASURE(S):
Clinical evaluation, serum ferritin concentration, and biochemical assessment of pituitary function were performed periodically.
RESULT(S):
One year after normalization of serum ferritin levels and transferrin saturation was achieved, he became eugonadal.
CONCLUSION(S):
We believe that hypogonadotropic hypogonadism in juvenile hemochromatosis may be reversible by a consequent venesection therapy probably because treatment was intensive and promptly introduced at a young age.
AuthorsNicholas G Angelopoulos, Anastasia Goula, Evagelos Dimitriou, George Tolis
JournalFertility and sterility (Fertil Steril) Vol. 84 Issue 6 Pg. 1744 (Dec 2005) ISSN: 1556-5653 [Electronic] United States
PMID16359978 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Transferrin
  • Ferritins
Topics
  • Adult
  • Age Factors
  • Ferritins (blood)
  • Hemochromatosis (complications, therapy)
  • Humans
  • Hypogonadism (etiology, therapy)
  • Male
  • Phlebotomy
  • Remission Induction
  • Transferrin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: